New partner: CLC bio, for a perfect complementarity between solutions

 

 

Genostar announces its new partnership with the Danish comapny CLC bio which provides the world's leading high-throughput sequence data analysis solutions.

 

We are proud to be the exclusive resellers for CLC bio in France.

 

 

 

CLC bio focuses on delivering fast, flexible, and user-friendly solutions to researchers working with analyzing high-throughput sequencing data from all the major and upcoming high-throughput sequencing platforms.

CLC bio offers a modern product portfolio, based on a 3-tier architecture consisting of user-friendly desktop clients for researchers, a powerful server structure with central execution of large jobs, as well a flexible integration with all major storage and database platforms available. This flexible setup scales from a single workstation, to labs of any size, and all the way up to large global corporations with multiple geographical sites.

CLC bio is the only company to support all major high-throughput sequencing platforms and also allowing to mix the data from the different platform to perform hybrid assemblies. Furthermore, CLC bio has used SIMD technology to optimize the calculations, so for example you can use a single powerful computer to de novo assemble a human genome, where open source algorithms require 10 times as much RAM or 20 times more CPU power to handle the same dataset.

 

 

CLC bio software complements Genostar's solutions perfectly. This combination provides a one-stop solution for reseachers: from NGS data to the analysis of genomic, proteic and metabolic data.

 

 

Some functionalities of CLC bio software:

• Reference assembly

• De novo assembly

• SNP & DIP detection
• Alignments & phylogenetic trees
• Primer design
• Molecular cloning
• ChIP-seq analysis
• And much more

For more information about CLC bio, please visit www.clcbio.com.

 

BACK